18
29th CINP World
Congress 2014
Preliminary Scientific Programme |
Wednesday, 25 June 2014
W-9
e
Scientific Workshop
10:00 – 11:30
Pathways to CNS drug discovery
Speakers: Anthony Phillips, Canada
Moussa Youdim, Israel
Peter H. Andersen, Denmark
S-25
e
Symposium
10:00 – 12:00
Topic: Pain (A)
Track: Basic
The expanding roles of microglia in chronic pain: Implica-
tions for therapy
Chair:
Michael Salter, Canada
Co-chair: Yves De Koninck, Canada
Gene regulation in microglia in neuropathic pain
Kazuhide Inoue, Japan
Microglia-neuron signaling mediates chronic pain-induced
alterations in reward pathways
Catherine Cahill, USA
The P2X4+ state of microglia is critical for neuropathic
pain
Michael Salter, Canada
Microglia-mediated disruption of neuronal Cl-homeosta-
sis mediates morphine hyperalgesia
Yves De Koninck, Canada
PL-06
e
Plenary Lecture
14:00 – 14:45
Optical deconstruction of fully-assembled biological systems
Karl Deisseroth, USA
S-26
e
Symposium
15:00 – 17:00
Topic: Depression (A)
Track: Translational
Depression in pregnancy and postpartum: A treatment
dilemma?
Chair:
John Kelly, Ireland
Co-chair: Marie-Christine Pardon, United Kingdom
Antidepressant treatment in a model of post-partum de-
pression age-dependently alter offspring’s CNS develop-
ment
Marie-Christine Pardon, United Kingdom
Maternal antidepressant exposure and CNS development
in the rat offspring
John Kelly, Ireland
What are the molecular and psychological mechanisms
underlying the impact of maternal depression and anti-
depressant use on the offspring?
Carmine Pariante, United Kingdom
Impact of in utero exposure to antidepressants on the
foetus
Margareta Reis, Sweden
S-27
e
Symposium
15:00 – 17:00
Topic: Clinical Investigator, National Funding Agency,
Public-Private Partnership initiated clinical trials in the
development of novel and effective CNS drugs and
stimulation devices (C)
Track: Clinical
A new nomenclature proposal for psychotropic drugs
Chair:
Stephen Stahl, USA
Co-chair: Joseph Zohar, Israel
Antidepressants
David Nutt, United Kingdom
Anxiolytics and hypnotics
Shigeto Yamawaki, Japan
Antipsychotics
Stephen Stahl, USA
Results of the nomenclature surveys among more than
1.000 practicing psychiatrists
Joseph Zohar, Israel
S-28
e
Symposium
15:00 – 17:00
Depression (A)
Track: Translational
Serotonin, stress and depression: Genetic and epigenetic
factors
Chair:
Paul Albert, Canada
Co-chair: Ramin V. Parsey, USA
Genetic mechanisms for longterm alterations in serotonin
in depression
Paul Albert, Canada
Increased serotonin-1A autoreceptor levels as trait of
major depression and treatment resistance
Ramin V. Parsey, USA
Steps and depression: A vicious cycle?
Cathérine Belzung, France
Genetic and epigenetic alterations in serotonin-regulating
genes and depression
Linda Booij, Canada
